(Q38040307)

27 August 2017

title

Type 2 diabetes and cardiovascular disease in women (English)

1 reference

27 August 2017

1 reference

cardiovascular disease

1 reference

cardiovascular disease in women

inferred from title

0 references

author name string

A Norhammar

series ordinal

1

1 reference

27 August 2017

K Schenck-Gustafsson

series ordinal

2

1 reference

27 August 2017

publication date

4 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

56

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

1-9

1 reference

27 August 2017

cites work

Health at a Glance 2011

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Representation of women in randomized clinical trials of cardiovascular disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Cardiovascular function/dysfunction in adolescents with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Diabetes mellitus, fasting glucose, and risk of cause-specific death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Mortality trends in men and women with diabetes, 1971 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Insulin resistance: sex matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Gestational diabetes, pregnancy hypertension, and late vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Cardiovascular sequelae of toxaemia of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Duration of lactation and incidence of myocardial infarction in middle to late adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Perspectives on dyslipidemia and coronary heart disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: evidence from the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Work stress, obesity and the risk of type 2 diabetes: gender-specific bidirectional effect in the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Hyperglycemia and adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Increased risk of cardiovascular disease in young women following gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Sex steroid hormones in diabetes-induced sexual dysfunction: focus on the female gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

EMAS position statement: Managing the menopause in the context of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Considerable disturbances of cardiovascular risk factors in women with diabetes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2694-Y

Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry

21 January 2018

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention

1 reference

12 December 2020

Silent myocardial ischemia in patients with diabetes: who to screen

1 reference

12 December 2020

Symptoms of men and women presenting with acute coronary syndromes

1 reference

12 December 2020

Validity of clinical diagnosis of heart failure in primary health care

1 reference

12 December 2020

Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000

1 reference

12 December 2020

Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes

1 reference

12 December 2020

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

1 reference

12 December 2020

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

12 December 2020

Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk

1 reference

12 December 2020

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus

1 reference

12 December 2020

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

1 reference

12 December 2020

10.1007/S00125-012-2694-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1030705995

0 references

1 reference